Thomas J Dilworth

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 5

Top Topics

Staphylococcus Aureus

Intensive Care Unit

Antimicrobial Resistance

Extracorporeal Membrane Oxygenation

Top Venues

Infection control and hospital epidemiology

Antimicrobial agents and chemotherapy

Journal of pharmacy practice

This page only lists publications with an associated author ORCID identifier.

Publications

Brian J Werth, Thomas J Dilworth, Zahra Kassamali Escobar, Alan E Gross, Katie J Suda, Andrew M Morris, Jessina C McGregor, Kristi M Kuper
Reporting behaviors and perceptions toward the National Healthcare Safety Network antimicrobial use (AU) and antimicrobial resistance (AR) modules. Infection control and hospital epidemiology (2022)
Thomas J Dilworth, Charles F Brummitt
Reduction in ambulatory visits for acute, uncomplicated bronchitis: an unintended but welcome result of the coronavirus disease 2019 (COVID-19) pandemic. Infection control and hospital epidemiology 42 (10) (2020)
Andrew Ackerman, Nathaniel R Zook, Jeremy F Siegrist, Charles F Brummitt, Margaret M Cook, Thomas J Dilworth
Comparison of Clinical Outcomes among Intensive Care Unit Patients Receiving One or Two Grams of Ceftriaxone Daily. Antimicrobial agents and chemotherapy 64 (6) (2020)
Calley M Paulson, Jillian F Handley, Thomas J Dilworth, Dan Persells, Rachael Y Prusi, Charles F Brummitt, Katherine M Torres, Lee P Skrupky
Impact of a Systematic Pharmacist-Initiated Antibiotic Time-Out Intervention for Hospitalized Adults. Journal of pharmacy practice (2020)
Courtney M Pagels, Thomas J Dilworth, Lynne Fehrenbacher, Maharaj Singh, Charles F Brummitt
Impact of an electronic best-practice advisory in combination with prescriber education on antibiotic prescribing for ambulatory adults with acute, uncomplicated bronchitis within a large integrated health system. Infection control and hospital epidemiology 40 (12) (2019)